Metabolomics Services Market Size, Share, Growth, and Forecast to 2025

Posted by rekha on September 13th, 2019

Precision Business Insights (PBI) in its report titled “Global Metabolomics Services Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024” assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global metabolomics services market was valued at US$ XX Mn in 2017 and increasing at a significant CAGR over the forecast timeframe owing to increase in government and private sector funding in metabolomics services, increase in integration of metabolomics data into healthcare and clinical workflow, and rise in R&D activities for the development of metabolomics services market are the major factors that are driving the growth of the global metabolomics services market over the forecast timeframe are expected to drive the global metabolomics services market. However, high cost of analytical instruments, lack of proper data management for metabolomic profiling and lack of skilled personnel are anticipated to hinder the revenue share of global metabolomics services market.

 Global metabolomics services market segmented on the basis of service type, sample type, sample source, end user and region.

 For request sample:

Separation and Detection Segment Dominates the Global Metabolomics Services Market

 Based on the service type, global metabolomics services market segmented into separation and detection and bioinformatics services. Separation and detection segment further divided into targeted metabolite assay, untargeted metabolite assays and lipidomics. Among them, separation and detection segment dominated the global metabolomics services market in 2018 and estimated to dominate over the forecast period owing to information provided by the service regarding the impact of metabolites in healthy and diseased patient, its benefits in diagnosing liver diseases, metabolic diseases and cancers among others and increase in the awareness regarding the benefits of early diagnosis are the factors drive the growth of separation and detection segment. However, a faster growth rate observed in bioinformatics segment owing to the increase in research and development.

North America Leads the Global Metabolomics Services Market

 PBI’s global metabolomics services market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to Increase in demand for personalized and targeted health care, increasing research funding and government initiatives in metabolomics and availability of sophisticated healthcare infrastructure are anticipated to propel the market. Asia pacific metabolomics services market projected to exhibit significant growth due toenhanced demand for biomarkers for the diagnosis of various life threatening diseases and enhanced awareness about various metabolomics technologies in the emerging countries such as China and India for detection, treatment, and prognosis of various genetic disorders such as diabetes, cancer, and other life threatening diseases.


 Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

 Global metabolomics services market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In 2019, Barc Lab and OWL metabolomics entered into strategic collaboration to deploy metabolomics technology in NASH clinical trials. Furthermore, few service providers are developing hand held metabolomic kits.

 Key player’s profiles in the report are

  • Lipotype GmbH (Germany)
  • Metanomics Health GmbH (Germany)
  • Metabolon, Inc. (US)
  • Metabolomic Discoveries GmbH (Germany)
  • OWL Metabolomics (Spain)
  • Creative Untargeted Metabolite Assay (US)
  • Stemina Biomarker Discovery, Inc (US)
  • Chenomx Inc.(Canada)
  • TMIC (Canada)
  • West Coast Metabolomics center (US)

Detailed Segmentation


Service Type

  • Separation & Detection Services
  • Lipidomics
  • Untargeted Metabolite Assay
  • Targeted Metabolite Assays
  • Bioinformatics Services


Sample Type

  • Urine
  • Tumor
  • Cell Culture Media
  • Whole Blood
  • Food Ingredients
  • Feces

Sample Source

  • Human
  • Animal
  • Others



End User

  • Healthcare Industry
  • Academic & Research Institutes
  • Food Processing Industry
  • Others



o     North America

  • U.S
  • Canada

o     Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information:

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author